NEW YORK (360Dx) – A*STAR’s Singapore Bioimaging Consortium (SBIC) and French research institute XLIM announced today a three-year research collaboration agreement to develop a surface enhanced raman scattering-based (SERS) biosensing platform.

The project's ultimate goal is to create an integrated sample collection and biosensing device that allows for detection of biomarkers in bodily fluids with picomolar to femtomolar levels of sensitivity, and without the need for upfront sample preparation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.